National Institute of Allergy and Infectious Diseases
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

Biodefense and Related Programs
 Biodefense
  About
  For Researchers
   Introduction
   Category A-C Pathogens
   Immunology of Biodefense
   Resources
   Funding
    FY2003 Awards
    FY2004 Awards
    FY2005 Awards
    FY2006 Awards
    FY2007 Awards
   Meetings
  Public and Media
 Radiation Countermeasures
 Chemical Countermeasures



Biodefense

Cooperative Research Partnerships for Influenza Product Development—FY2007 Awards

Institution PI Name Title
Alphavax Human Vaccines, Inc. Smith, Jonathan Alphavirus Replicon Vectors as Dose-Sparing Adjuvants for Influenza Vaccines.
Dana-Farber Cancer Institute Marasco, Wayne A. Human Mab Cocktails to Prevent & Treat H5n1 Avian Influenza
Duke University Gunn, Michael D. Prevention of Immune Pathology during Avian Influenza Infection
Dynavax Technologies Corporation Van Nest, Gary A. Production of an Np-Iss Conjugate Vaccine to Combat Pandemic Influenza.
Emory University Compans, Richard W. Self-Administered Microneedle Patches for Influenza Vaccines
Idaho Technology Dobrowolski, Steven F. Ht-Film-Array: A System to Assess Respiratory Viruses with Emphasis on Influenza
Juvaris Biotherapeutics, Inc. Fairman, Jeff C. Adjuvant Enhanced Antiviral Immunity
Lovelace Biomedical & Environmental Res. Koster, Frederick T. T5000 Diagnostic System in Ferret Model of Influenza
Massachusetts General Hospital Takahashi, Kazue Development of Novel Immunotherapy for Influenza Virus Infection
Massachusetts General Hospital Hacohen, Nir Identification and Validation of Influenza Host Factors as Therapeutic Targets
Massachusetts Institute of Technology Chen, Jianzhu Bi-Functional Polymer-Attached Inhibitors of Influenza Viruses
Molecular Express, Inc. Fujii, Gary Non-Viral Pandemic Influenza Vaccine Development
Mount Sinai School of Medicine of Nyu Palese, Peter M. Novel Cellular and Viral Targets for Anti-Influenza Virus Drugs
Scripps Research Institute Oldstone, Michael B. Novel Chemical and Immunological Approaches to Influenza Therapy
Swiss Federal Inst. of Tech. (Eth Zurich) Helenius, Ari Development of Anti-Influenza Agents by a Systems Biology Approach
University of British Columbia Mcelhaney, Janet E. Adjuvants and Virosomal Vaccines for the Elderly
University of California San Diego Schooley, Robert Turner Multiplex Nucleic Acid Detection Devices for the Diagnosis of Respiratory Viruses
University of Pittsburgh at Pittsburgh Fuller, Deborah H. DNA Vaccine for Seasonal & Pandemic Influenza
University of Texas Austin Krug, Robert M. Targeting the Ns1 Protein for the Development of Influenza Virus Antivirals
University Of Wisconsin Madison Kawaoka, Yoshihiro Nanoemulsions as Novel Adjuvents for Influenza Virus Vaccines
Vical, Inc. Smith, Lawrence R. Pandemic Influenza DNA Vaccine Development

back to top